23 results
425
SPRC
SciSparc Ltd
12 Apr 24
Business combination disclosure
9:23am
proposed new products, services or developments; any statements concerning the attraction and retention of highly qualified personnel; any statements … for change in control, stay or retention, deferred compensation, incentive compensation, pension and severance benefits. “Company Benefit Plan” means each
6-K
EX-99.1
SPRC
SciSparc Ltd
11 Apr 24
Agreement and Plan of Merger
4:05pm
or retention, deferred compensation, incentive compensation, pension and severance benefits. “Company Benefit Plan” means each pension, profit sharing, bonus … be required to be disclosed in Parent’s financial statements in accordance with IFRS.
(c) Parent’s auditor has at all times since its retention by Parent
6-K
SPRC
SciSparc Ltd
11 Apr 24
Agreement and Plan of Merger
4:05pm
statements concerning proposed new products, services or developments; any statements concerning the attraction and retention of highly qualified personnel
F-1
EX-10.7
SPRC
SciSparc Ltd
27 Feb 24
Registration statement (foreign)
4:15pm
shall solely be at the risk of the Grantee.
NO RETENTION RIGHTS.
Nothing in this Plan, any Award Agreement or in any Award granted or agreement
F-1
zo1xl i4ljodmj0p
27 Feb 24
Registration statement (foreign)
4:15pm
6-K
EX-10.4
a0q54
12 Oct 23
SciSparc Ltd. Announces Pricing of $5.026 Million Private Placement
8:48am
6-K
EX-99.1
0keh ej0tpfs1qp7lc
16 May 23
At-The-Market Issuance Sales Agreement
8:06pm
6-K
EX-99.3
i2ufjre779g6digqqkf
30 Sep 22
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
7:27am
6-K
EX-99.1
8mstbeqtmoa72qxu
11 Aug 22
Current Report
4:05pm
6-K
EX-99.1
6pxgf3tf
7 Jul 22
Report of Foreign Private Issuer
4:00pm
6-K
EX-99.4
b1vua3b
27 May 22
SciSparc Announces Pricing of $10 Million Private Placement Priced At-the-Market
4:10pm
6-K
EX-99.1
t81pasak
6 Jan 22
Report of Foreign Private Issuer
4:02pm
F-6 POS
EX-1
zhr1rzpr
26 Jul 21
Automatic registration for ADRs (post-effective amendment, foreign)
10:38am
6-K
EX-99.1
qx6fvd
25 Jan 21
Special General Meeting of Shareholders
5:27pm
6-K
EX-1.1
rjr1p an6wry2
24 Nov 20
Therapix Biosciences Announces Pricing of $4.2 Million Offering
1:13pm
F-1/A
EX-1.1
vssq78byuag eu
4 Nov 20
Registration statement (foreign) (amended)
2:14pm